Filing Details
- Accession Number:
- 0001144204-18-013389
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-07 17:00:56
- Reporting Period:
- 2018-03-05
- Accepted Time:
- 2018-03-07 17:00:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1023024 | Ani Pharmaceuticals Inc | ANIP | Pharmaceutical Preparations (2834) | 582301143 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1579587 | G. James Marken | C/O Ani Pharmaceuticals, Inc. 210 Main Street West Baudette MN 56623 | Svp Ops & Prod Dev | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-03-05 | 14,793 | $6.36 | 66,439 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-03-05 | 3,208 | $33.00 | 69,647 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-03-05 | 4,177 | $61.92 | 65,470 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options | Disposition | 2018-03-05 | 14,793 | $0.00 | 14,793 | $6.36 |
| Common Stock | Stock Options | Disposition | 2018-03-05 | 3,208 | $0.00 | 3,208 | $33.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2024-03-31 | No | 4 | M | Direct | |
| 1,667 | 2023-07-11 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $62.80 to $63.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The options vested and become exercisable in equal annual amounts over a four-year period beginning on the first anniversary of the grant date. The grant date was July 12, 2013.
- The options vested and become exercisable in equal annual amounts over a four-year period beginning on the first anniversary of the grant date. The grant date was April 1, 2014.
Billionaire Hedge Funds
